Konrad Dobschuetz, Founder Director of Leap Advisory and Intelligence is a recognised global HealthTech leader. He can provide over 20 years of commercial innovation expertise from founding his own business to working for multi nationals. In healthcare, Konrad is focussed on the commercial adoption of impactful digital innovations contributing to positive patient and societal outcomes. In his work with key health systems and industry in the UK and UK, he zooms in on emerging tech such as AI in diagnostics, pathway management and risk prediction. Konrad has worked as National Director for NHS England, life sciences companies such as Novartis and Pfizer, driving large scale digital transformation initiatives across a range of markets and implementing innovations for example to identify future patient needs using AI prediction. He also brings in relationships to leading LifeSciences companies such as AstraZeneca, Janssen and Sanofi. Konrad is a frequent speaker at major conferences advocating for the equity of access to AI augmented services and more collaboration between LifeSciences, public sector, private investment and tech; a space he comfortable navigates within.
Start the second day with insightful remarks from our Chairperson
Konrad Dobschuetz
Founder Director at Leap Advisory & Intelligence
Konrad Dobschuetz
Founder Director at Leap Advisory & Intelligence
Stijn Janssen
Design Lead Data Science at Novo Nordisk
Leyla Hernandez Donoso
Senior Director of Real-World Evidence at Novo Nordisk
Sravan Kumar Eduru
Angel Investor & AI Start up Advisor
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
Konrad Dobschuetz
Founder Director at Leap Advisory & Intelligence
For general conference and registration enquires please contact the below email id or via call
Login 
Thursday - May 29, 2025
08:50
AM -
09:00
AM 
10
Minutes
info@corvusglobalevents.com
+44
(0)
207
096 0786
